NCT03742895 2026-02-18
MK-7339-002
Merck Sharp & Dohme LLC
Phase 2 Active not recruiting
Clinical Trials
3 trialsNCT03338881 2023-02-08
A Study to Assess Mass Balance, Pharmacokinetics (PK), and Metabolism of Orally Administered [14 C]-TAK-659 in Participants With Advanced Solid Tumor and/or Lymphoma Malignancies
Calithera Biosciences, Inc
Phase 1 Withdrawn
NCT02829099 2022-10-06
A Study of Safety, Pharmacokinetics and Pharmacodynamics of JNJ-64457107 in Participants With Advanced Stage Tumors
Janssen Research & Development, LLC
Phase 1 Completed